Axial spondyloarthritis: treatment strategy
The article presents a recent study on the research of new developments in the treatment of axial spondyloarthritis - radiographic (ankylosing spondylitis), and nonradiographic spondylitis in accordance with the criteria of the International Society for the Evaluation of Spondylarthritis. The basis for starting drug therapy is non-steroidal antiinflammatory drugs, whose high efficacy is one of the diagnostic criteria for this group of diseases. Many studies have demonstrated the modulation of the immune response through therapy with anti-cytokine drugs, cytokine receptor blockers, T-cell costimulation inhibitors for axial spondyloarthritis, which can reduce the activity of the disease, and in some cases prevent its X-ray progression.